complexity science; COVID-19; epidemiology; health policies; SARS-CoV-2
Résumé :
[en] Abstract Chimamanda Ngozi Adichie showed how a single story is limited and thereby distorts the true nature of an issue. During this COVID-19 pandemic there have been, at least, three consecutive single stories—the ‘lethal threat’ story, followed by the ‘economic threat’ story, and finally the ‘vaccine miracle’ story. None of these single stories can convincingly and permanently capture the dynamics of the pandemic. This is because countries experienced different morbidity and mortality patterns, different socioeconomic disadvantage, age and vulnerability of population, timing and level of lockdown with economic variability, and, despite heavy promotion, vaccines were beset with a significant and variable degree of hesitancy. Lack of transparency, coherence and consistency of pandemic management—arising from holding on to single storylines—showed the global deficiency of public health policy and planning, an underfunding of (public) health and social services, and a growing distrust in governments' ability to manage crises effectively. Indeed, the global management has increased already large inequities, and little has been learnt to address the growing crises of more infectious and potentially more lethal virus mutations. Holding onto single stories prevents the necessary learnings to understand and manage the complexities of ‘wicked’ problems, whereas listening to the many stories provides insights and pathways to do so effectively as well as efficiently.
Disciplines :
Santé publique, services médicaux & soins de santé
Auteur, co-auteur :
Sturmberg, Joachim
Paul, Elisabeth ; Université de Liège - ULiège > Département des sciences sociales > Sociologie du développement
Van Damme, Wim
Ridde, Valery
Brown, Garrett W.
Kalk, Andreas
Langue du document :
Anglais
Titre :
The danger of the single storyline obfuscating the complexities of managing SARS-CoV-2/COVID-19
Adichie CN. The danger of a single story [Internet]. Podcast. 2009. Accessed November 21, 2021. https://www.youtube.com/watch?v=D9Ihs241zeg
Paul E, Brown GW, Dechamps M, et al. Covid-19: an extra-terrestrial disease? Int J Infect Dis. 2021;110:155-159. doi:10.1016/j.ijid.2021.07.051
Waya JLL, Ameh D, Mogga JLK, Wamala JF, Olu OO. COVID-19 case management strategies: what are the options for Africa? Infect Dis Poverty. 2021;10(1):30. doi:10.1186/s40249-021-00795-7
Campeau L, Degroote S, Ridde V, Carabali M, Zinszer K. Containment measures for emerging and re-emerging vector-borne and other infectious diseases of poverty in urban settings: a scoping review. Infect Dis Poverty. 2018;7(1):95. doi:10.1186/s40249-018-0478-4
Ziady H. The global economic bailout is running at $19.5 trillion. It will go higher. CNN Business. 2020. Accessed November 21, 2021. https://edition.cnn.com/2020/11/17/economy/global-economy-coronavirus-bailout-imf-annual-report/index.html
The World Bank. The global economic outlook during the COVID-19 pandemic: a changed world. 2020. Accessed November 21, 2021. https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-world
Beer T. All the times trump compared Covid-19 to the flu, even after he knew Covid-19 was far more deadly. Forbes. 2020. Accessed November 21, 2021. https://www.forbes.com/sites/tommybeer/2020/09/10/all-the-times-trump-compared-covid-19-to-the-flu-even-after-he-knew-covid-19-was-far-more-deadly/?sh=73b2f774f9d2
Fletcher M. The biggest mistakes made by Boris Johnson's government during the Covid-19 crisis. New Statesman. 2020. Accessed November 21, 2021. https://www.newstatesman.com/politics/uk-politics/2020/11/biggest-mistakes-made-boris-johnson-s-government-during-covid-19-crisis
Jeantet D. Brazil COVID-19 death toll tops 250,000. The Canberra Times. 2021. Accessed November 21, 2021. https://www.canberratimes.com.au/story/7143826/brazil-covid-19-death-toll-tops-250000/
Skegg DC, Hill PC. Defining COVID-19 Elimination. BMJ. 2021;374:n1794. doi:10.1136/bmj.n1794
De Foo C, Grépin KA, Cook AR, et al. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore. Lancet. 2021;398(10311):1547-1551. doi:10.1016/S0140-6736(21)02186-3
Cambon L, Bergeron H, Castel P, Ridde V, Alla F. When the worldwide response to the COVID-19 pandemic is done without health promotion. Glob Health Promot. 2021;28(2):3-6. doi:10.1177/17579759211015129
Abella BS, Jolkovsky EL, Biney BT, et al. Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial. JAMA Intern Med. 2021;181(2):195-202. doi:10.1001/jamainternmed.2020.6319
Ohl ME, Miller DR, Lund BC, et al. Association of Remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19. JAMA Netw Open. 2021;4(7):e2114741. doi:10.1001/jamanetworkopen.2021.14741
Paul E, Brown GW, Kalk A, Ridde V. Playing vaccine roulette: why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager. Vaccine. 2021;39(35):4921-4924. doi:10.1016/j.vaccine.2021.07.045
Estola T. Coronaviruses, a new group of animal RNA viruses. Avian Dis. 1970;14(2):330-336. doi:10.2307/1588476
Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020;4:66-75. doi:10.15698/cst2020.04.216
Piplani S, Singh PK, Winkler DA, Petrovsky N. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin. Sci Rep. 2021;11(1):13063. doi:10.1038/s41598-021-92388-5
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med. 2020;174(2):286–287. doi:10.7326/L20-1285
Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603-1605. doi:10.1016/s0140-6736(21)00869-2
Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585. doi:10.1126/science.abd4585
Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4570. doi:10.1126/science.abd4570
Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489-1501. doi:10.1016/j.cell.2020.05.015
Ioannidis JPA. Reconciling estimates of global spread and infection fatality rates of COVID-19: an overview of systematic evaluations. Eur J Clin Invest. 2021;51(5):e13554. doi:10.1111/eci.13554
Adhanom Ghebreyesus T. WHO Director-General's opening remarks at the media briefing on COVID-19. 2020. Accessed November 21, 2021. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020
Mercuri M. Don't panic, it is only an emergency. J Eval Clin Pract. 2020;26(3):685-686. doi:10.1111/jep.13394
Mallapaty S. How deadly is the coronavirus? Scientists are close to an answer. Nature. 2020;582(7813):467-468. doi:10.1038/d41586-020-01738-2
Ioannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99(1):19-33f. doi:10.2471/blt.20.265892
Ioannidis JPA. Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. Eur J Clin Invest. 2020;50(4):e13222. doi:10.1111/eci.13222
Ioannidis John PA. A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data. 2020. Accessed November 21, 2021. https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/
Lipsitch M. We know enough now to act decisively against Covid-19. Social distancing is a good place to start. StatNews. 2020. Accessed November 21, 2021. Available from: https://www.statnews.com/2020/03/18/we-know-enough-now-to-act-decisively-against-covid-19/
Bastian H. A rebuttal to Ioannidis' “A fiasco in the making?”. 2020. Accessed November 21, 2021. https://hildabastian.net/index.php/8-secondary/87
Crowe K. Prominent scientist dares to ask: Has the COVID-19 response gone too far? Leading epidemiologists publish duelling commentaries, igniting debate on social media. CBC News. 2020. Accessed November 21, 2021. https://www.cbc.ca/news/health/coronavirus-covid-pandemic-response-scientists-1.5502423
Reichmann JP. Letter to the Editor Re: coronavirus disease 2019: the harms of exaggerated information and nonevidence-based measures. Eur J Clin Invest. 2020;50(5):e13224. doi:10.1111/eci.13224
Buranyi S. Talk of a scientific rift is a dangerous distraction in the fight against Covid-19. The Guardian. 2020. Accessed November 21, 2021. https://www.theguardian.com/commentisfree/2020/sep/29/rival-scientists-lockdowns-scientific-covid-19
Mahase E. Covid-19: what do we know about “long covid?” BMJ. 2020;370:m2815. doi:10.1136/bmj.m2815
Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426
Scherlinger M, Felten R, Gallais F, et al. Refining “Long-COVID” by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect Dis Ther. 2021;10:1-17. doi:10.1007/s40121-021-00484-w
Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi:10.1001/jamanetworkopen.2021.11417
Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869-875. doi:10.1016/j.dsx.2021.04.007
Barber C. The Problem of ‘Long Haul’ COVID. Scientific American. 2020. Accessed November 21, 2021. https://www.scientificamerican.com/article/the-problem-of-long-haul-covid/
Basu T. Covid-19 “long haulers” are organizing online to study themselves. MIT Technology Review. 2020. Accessed November 21, 2021. https://www.technologyreview.com/2020/08/12/1006602/covid-19-long-haulers-are-organizing-online-to-study-themselves/
Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35(12):1123-1138. doi:10.1007/s10654-020-00698-1
O'Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140-145. doi:10.1038/s41586-020-2918-0
Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc Health. 2021;5(5):e12-e13. doi:10.1016/s2352-4642(21)00066-3
Wong JY, Kelly H, Ip DKM, Wu JT, Leung GM, Cowling BJ. Case fatality risk of influenza A (H1N1pdm09): a systematic review. Epidemiology. 2013;24(6):830-841. doi:10.1097/EDE.0b013e3182a67448
Statista. Influenza mortality rate during the 2018-2019 flu season in the United States, by age group New York, US: Statista Inc.; 2021. Accessed November 21, 2021. https://www.statista.com/statistics/1127799/influenza-us-mortality-rate-by-age-group/
Bartoloni A, Zammarchi L. Clinical aspects of uncomplicated and severe malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012026. doi:10.4084/mjhid.2012.026
Mayo Clinic Staff. Malaria. Mayo Foundation for Medical Education and Research (MFMER) [Internet]. 2021. Accessed November 21, 2021. https://www.mayoclinic.org/diseases-conditions/malaria/symptoms-causes/syc-20351184
Byard RW. Lethal dengue virus infection: a forensic overview. Am J Forensic Med Pathol. 2016;37(2):74-78. doi:10.1097/paf.0000000000000236
Smith DS, Mariano DJ, Trautwein ML. Dengue. Medscape [Internet]. 2019. Accessed November 21, 2021. https://emedicine.medscape.com/article/215840-overview#a1
Slovic P. Perception of risk. Science. 1987;236(4799):280-285. doi:10.1126/science.3563507
Thinking KD. Fast and Slow. Farrar, Straus and Giroux; 2011.
Brown VJ. Risk perception: it's personal. Environ Health Perspect. 2014;122(10):A276-A279. doi:10.1289/ehp.122-A276
Bonnet E, Nikiéma A, Adoléhoume A, Ridde V. Better data for better action: rethinking road injury data in francophone West Africa. BMJ Glob Health. 2020;5(5):e002521. doi:10.1136/bmjgh-2020-002521
Mercatelli D, Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol. 2020;11:1800. doi:10.3389/fmicb.2020.01800
Lazarevic I, Pravica V, Miljanovic D, Cupic M. Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses. 2021;13(7):1192. doi:10.3390/v13071192
Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi:10.1126/science.abg3055
Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 17. London: Public Health England. Contract No.: GOV-8715. June 25, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1005517/Technical_Briefing_19.pdf
Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741-745. doi:10.1126/science.abe6522
Day T, Gandon S, Lion S, Otto SP. On the evolutionary epidemiology of SARS-CoV-2. Curr Biol. 2020;30(15):R849-r57. doi:10.1016/j.cub.2020.06.031
Wamai RG, Hirsch JL, Van Damme W, et al. What could explain the lower COVID-19 burden in Africa despite considerable circulation of the SARS-CoV-2 virus? Int J Environ Res Public Health. 2021;18(16):8638. doi:10.3390/ijerph18168638
Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(34):e2109229118. doi:10.1073/pnas.2109229118
Wild P. Studie obotGC—Gutenberg COVID-19 Studie. Ergebnisse aus einer bevolkerungsreprasentativen Studie Mainz: UniversitätsMedizin Mainz; 2021. Accessed November 21, 2021. https://www.unimedizin-mainz.de/GCS/dashboard/#/app/pages/AktuelleErgebnisse/ergebnisse
Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife. 2020;9:e59177. doi:10.7554/eLife.59177
Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage—a review. Life Sci. 2020;255:117839. doi:10.1016/j.lfs.2020.117839
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102-108. doi:10.1016/j.jpha.2020.03.001
Elezkurtaj S, Greuel S, Ihlow J, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 2021;11(1):4263. doi:10.1038/s41598-021-82862-5
Tan AX, Hinman JA, Abdel Magid HS, Nelson LM, Odden MC. Association between income inequality and county-level COVID-19 cases and deaths in the US. JAMA Netw Open. 2021;4(5):e218799. doi:10.1001/jamanetworkopen.2021.8799
Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston. JAMA. 2020;323:2191-2192. doi:10.1001/jama.2020.6887
Rice BL, Annapragada A, Baker RE, et al. Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa. Nat Med. 2021;27(3):447-453. doi:10.1038/s41591-021-01234-8
Agence Nationale de la Statistique et de la Démographie. Recensement general de la population et de l'habitat, de l'agriculture et de l'élevage. Dakar; 2014. Accessed November 21, 2021. https://www.ansd.sn/ressources/rapports/Rapport-definitif-RGPHAE2013.pdf
Jessop J. The UK lockdown and the economic value of human life. Econ Aff. 2020;40(2):138-147. doi:10.1111/ecaf.12417
Bavli I, Sutton B, Galea S. Harms of public health interventions against Covid-19 must not be ignored. BMJ. 2020;371:m4074. doi:10.1136/bmj.m4074
World Health Organization (WHO). International Health Regulations. 2nd ed. World Health Organization; 2005.
Rozenblum Sarah D. France's multidimensional COVID-19 response. Ad Hoc Committees and the sidelining of Public Health Agencies. In: Greer Scott L, King Elizabeth J, Fonseca EM, Peralta-Santos A, eds. Coronavirus Politics. The Comparative Politics and Policy of COVID-19. University of Michigan Press; 2021:264-279.
Or Z, Gandré C, Durand Zaleski I, Steffen M. France's response to the Covid-19 pandemic: between a rock and a hard place. Health Econ Policy Law. Published online March 5, 2021. doi:10.1017/S1744133121000165
Cour des comptes. Le Financement De La Recherche Publique Dans La Lutte Contre La Pandémie De Covid-19. June 17, 2021. Accessed November 21, 2021. https://www.ccomptes.fr/system/files/2021-07/20210730-financement-recherche-publique-Covid.pdf
Hudson C, Watson B, Baker A, Arsov I. The Global Fiscal Response to COVID-19. June 17, 2021. Accessed November 21, 2021. https://www.rba.gov.au/publications/bulletin/2021/jun/the-global-fiscal-response-to-covid-19.html
Morris M. Shareholders reap millions from top companies pocketing JobKeeper, new analysis finds. ABC News. 2021. Accessed November 21, 2021. https://www.abc.net.au/news/2021-03-26/top-companies-pocketing-jobkeeper-new-analysis-finds/100030274
Ngo M. Small businesses are dying by the thousands—and no one is tracking the carnage. Bloomberg. 2020. Accessed November 21, 2021. https://www.bloomberg.com/news/articles/2020-08-11/small-firms-die-quietly-leaving-thousands-of-failures-uncounted
Kyodo News. Nonregular workers at big firms left out of virus-related benefits. 2021. Accessed November 21, 2021. https://english.kyodonews.net/news/2021/02/9939800d29e0-nonregular-workers-at-big-firms-left-out-of-virus-related-benefits.html
Montpetit J, Nakonechny S, Hétu M-H. Why millions of dollars in pandemic aid is going to corporations making healthy profits. CBC News. 2020. Accessed November 21, 2021. https://www.cbc.ca/news/canada/montreal/cews-wage-subsidy-jobs-covid-1.5834790
Greive D. Covid 19 coronavirus: Some of NZ's biggest businesses are making huge profits—thanks to the wage subsidy. NZ Herald. 2020. https://www.nzherald.co.nz/nz/covid-19-coronavirus-some-of-nzs-biggest-businesses-are-making-huge-profits-thanks-to-the-wage-subsidy/ROIMHEWMKXGBRJFUMWNDZIWTVM/
Chakrabarti S, Hamlet LC, Kaminsky J, Subramanian SV. Association of human mobility restrictions and race/ethnicity–based, sex-based, and income-based factors with inequities in well-being during the COVID-19 pandemic in the United States. JAMA Netw Open. 2021;4(4):e217373. doi:10.1001/jamanetworkopen.2021.7373
Carillon S, Gosselin A, Coulibaly K, Ridde V, Desgrées, du Loû A. Immigrants facing Covid 19 containment in France: an ordinary hardship of disaffiliation. J Migr Health. 2020;1-2:100032. doi:10.1016/j.jmh.2020.100032
Gautier L, Poveda J-D, Nguengang Wakap S, Bouchon M, Quesnel-Vallée A. Adapting care provision and advocating for unprotected unaccompanied minors in Paris in the context of COVID-19. Glob Health Promot. 2021;28(1):75-78. doi:10.1177/1757975920984193
Pea V. Voix du Congo—Rapport 21. UNDP, Havard Humanitarian Initiative, Brigham and Women's Hospital, MONUSCO; November 2020.
Egger D, Miguel E, Warren SS, et al. Falling living standards during the COVID-19 crisis: quantitative evidence from nine developing countries. Sci Adv. 2021;7(6):eabe0997. doi:10.1126/sciadv.abe0997
Rios B. ILO warns of ‘devastating’ consequences of COVID-19 on labour markets. 2020. Accessed November 21, 2021. https://www.euractiv.com/section/economy-jobs/news/ilo-warns-of-devastating-consequences-of-covid-19-on-labour-markets/
République du Sénégal. Comité de suivi de la mise en œuvre des opérations du Fonds “Force Covid-19”. 2021.
Paulus D. How politicians talk about coronavirus in Germany, where war metaphors are avoided. The Conversation. 2020. Accessed November 21, 2021. https://theconversation.com/how-politicians-talk-about-coronavirus-in-germany-where-war-metaphors-are-avoided-137427
Coady CAJ. The problem of dirty hands. Stanford Encyclopedia of Philosophy Archive. Metaphysics Research Lab, Stanford University; 2018.
Turcotte-Tremblay A-M, Gali Gali IA, Ridde V. The unintended consequences of COVID-19 mitigation measures matter: practical guidance for investigating them. BMC Med Res Methodol. 2021;21(1):28. doi:10.1186/s12874-020-01200-x
Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16(1):57. doi:10.1186/s12992-020-00589-w
The Global Fund. The impact of COVID-19 on HIV, Tb and malaria services and systems for health: a snapshot from 502 health facilities across Africa and Asia. Geneva, Switzerland: The Global Fund to Fight AIDS, Tuberculosis and Malaria. 2021. Accessed November 21, 2021. https://reliefweb.int/sites/reliefweb.int/files/resources/covid-19_2020-disruption-impact_report_en.pdf
Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):e759-e772. doi:10.1016/s2214-109x(21)00079-6
Christakis DA, Van Cleve W, Zimmerman FJ. Estimation of US children's educational attainment and years of life lost associated with primary school closures during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3(11):e2028786. doi:10.1001/jamanetworkopen.2020.28786
Alexander PE, Tenenbaum HC, Oskoui R, Dara P, Wax CM. School closure: a careful review of the evidence: American Institute of Educational Research; 2021. Accessed November 21, 2021. https://www.aier.org/article/school-closure-a-careful-review-of-the-evidence/
Mazza M, Marano G, Lai C, Janiri L, Sani G. Danger in danger: interpersonal violence during COVID-19 quarantine. Psychiatry Res. 2020;289:113046. doi:10.1016/j.psychres.2020.113046
The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2020;384(8):693-704. doi:10.1056/NEJMoa2021436
Baigrie B, Mercuri M. Relevance, validity, and evidential reasoning in clinical practice. J Eval Clin Pract. 2020;26(5):1341-1343. doi:10.1111/jep.13474
Perillat L, Baigrie BS. COVID-19 and the generation of novel scientific knowledge: evidence-based decisions and data sharing. J Eval Clin Pract. 2021;27(3):708-715. doi:10.1111/jep.13548
Vaughn VM, Yost M, Abshire C, et al. Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19. JAMA Netw Open. 2021;4(6):e2111788. doi:10.1001/jamanetworkopen.2021.11788
Byttebier G, Belmans L, Alexander M, et al. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother. 2021;17:1-10. doi:10.1080/21645515.2021.1920271
Fedson DS. COVID-19, host response treatment, and the need for political leadership. J Public Health Policy. 2021;42(1):6-14. doi:10.1057/s41271-020-00266-7
Zhao Y, Nie H-X, Hu K, et al. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty. 2020;9(1):108. doi:10.1186/s40249-020-00723-1
Tian T, Zhang J, Hu L, et al. Risk factors associated with mortality of COVID-19 in 3125 counties of the United States. Infect Dis Poverty. 2021;10(1):3. doi:10.1186/s40249-020-00786-0
Paul E, Brown GW, Ridde V. COVID-19: time for paradigm shift in the nexus between local, national and global health. BMJ Glob Health. 2020;5(4):e002622. doi:10.1136/bmjgh-2020-002622
Paul E, Brown GW, Kalk A, Van Damme W, Ridde V, Sturmberg J. “When My Information Changes, I Alter My Conclusions.” What can we learn from the failures to adaptively respond to the SARS-CoV-2 pandemic and the under preparedness of health systems to manage COVID-19? Int J Health Policy Manag. Published online November 29, 2020. doi:10.34172/ijhpm.2020.240
Pradhan A, Olsson P-E. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020;11(1):53. doi:10.1186/s13293-020-00330-7
Higgins T, Stark M, Henson K, Freeseman-Freeman L. Coronavirus disease 2019 ICU patients have higher-than-expected acute physiology and chronic health evaluation-adjusted mortality and length of stay than viral pneumonia ICU patients. Crit Care Med. 2021;49(7):e701-e706. doi:10.1097/CCM.0000000000005012
Yates T. Why is the government relying on nudge theory to fight coronavirus? The Guardian. 2020. Accessed November 21, 2021. https://www.theguardian.com/commentisfree/2020/mar/13/why-is-the-government-relying-on-nudge-theory-to-tackle-coronavirus
John P, Stoker G. Behavioural science and the response to COVID-19: a missed opportunity? [Internet]: London School of Economics. 2020. Accessed November 21, 2021. https://blogs.lse.ac.uk/politicsandpolicy/behavioural-science-covid19/
Fajnzylber J, Regan J, Coxen K, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493. doi:10.1038/s41467-020-19057-5
de la Calle C, Lalueza A, Mancheño-Losa M, et al. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(6):1209-1216. doi:10.1007/s10096-020-04150-w
Grant JJ, Wilmore SMS, McCann NS, et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infect Control Hosp Epidemiol. 2021;42(2):212-214. doi:10.1017/ice.2020.402
Poletti P, Tirani M, Cereda D, et al. Seroprevalence of and risk factors associated with SARS-CoV-2 infection in health care workers during the early COVID-19 pandemic in Italy. JAMA Netw Open. 2021;4(7):e2115699. doi:10.1001/jamanetworkopen.2021.15699
Australian Government, Department of Health. COVID-19 vaccination to become mandatory for residential aged care workers. 2021. Accessed November 21, 2021. https://www.health.gov.au/news/announcements/covid-19-vaccination-to-become-mandatory-for-residential-aged-care-workers
Shrestha NK, Burke PC, Nowacki AS, Terpeluk P, Gordon SM. Necessity of COVID-19 vaccination in previously infected individuals. medRxiv. 2021. doi:10.1101/2021.06.01.21258176
Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158-168. doi:10.1016/j.cell.2020.08.017
Rosenberg D. Natural infection vs vaccination: which gives more protection? 2021. Accessed November 21, 2021. https://www.israelnationalnews.com/News/News.aspx/309762?fbclid=IwAR19FuowMtQIlqBnu3Zqt5ajPAv-t3CdPBQz4aQhKvGZ4EPoOaaw0B5liuE
World Health Organization. Strategy to achieve global Covid-19 vaccination by mid-2022. Geneva: World Health Organisation. 2021. Accessed November 21, 2021. https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf?sfvrsn=5a68433c_5
Centers for Disease Control and Prevention. Selected adverse events reported after COVID-19 vaccination. 2021. Accessed November 21, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
Al Khames Aga QA, Alkhaffaf WH, Hatem TH, et al. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588-6594. doi:10.1002/jmv.27214
Department of Health. Patient information sheet on AstraZeneca COVID-19 vaccine and thrombosis with thrombocytopenia syndrome (TTS). Canberrra: Australian Government. 2021. Accessed November 21, 2021. https://www.health.gov.au/resources/publications/patient-information-sheet-on-astrazeneca-covid-19-vaccine-and-thrombosis-with-thrombocytopenia-syndrome-tts
Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021;39:101061. doi:10.1016/j.eclinm.2021.101061
Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. Science Magazine. 2021. Accessed November 21, 2021. https://www.sciencemag.org/news/2021/06/israel-reports-link-between-rare-cases-heart-inflammation-and-covid-19-vaccination
Paul-Ehrlich-Institut Sicherheitsbericht. Verdachtsfälle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19 seit Beginn der Impfkampagne am 27.12.2020 bis zum 31.08.20212021. Accessed November 21, 2021. https://www.pei.de/SharedDocs/Downloads/EN/newsroom-en/dossiers/safety-reports/safety-report-27-december-31-august-2021.pdf?__blob=publicationFile%26v=5
Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization. Nature. 2021;596:276-280. doi:10.1038/s41586-021-03777-9
Neergaard L. Pfizer to seek OK for 3rd vaccine dose; shots still protect. AP News. 2021. Accessed November 21, 2021. https://apnews.com/article/europe-coronavirus-pandemic-science-health-34c3f2536747a7c08980d7359a8de70c
Mandavilli A. Pfizer and BioNTech will test a vaccine against the delta variant. The New York Times. July 10, 2021. Accessed November 21, 2021. https://www.nytimes.com/live/2021/07/08/world/covid-19-vaccine-coronavirus-updates?smid=url-share-live#pfizer-and-biontech-will-test-a-vaccine-against-the-delta-variant
Klement RJ. Systems thinking about SARS-CoV-2. Front Public Health. 2020;8(650):585229. doi:10.3389/fpubh.2020.585229
Sturmberg JP, Martin CM. COVID-19—how a pandemic reveals that everything is connected to everything else. J Eval Clin Pract. 2020;26(5):1361-1367. doi:10.1111/jep.13419
Sturmberg JP. COVID-19 highlights the failings of the health system as a whole. BMJ. 2020;370:m3329. doi:10.1136/bmj.m3329
Donovan J. How COVID-19 has changed public policy. 2020. Accessed November 21, 2021. https://www.hks.harvard.edu/faculty-research/policy-topics/public-leadership-management/how-covid-19-has-changed-public-policy
Ackoff RL. Systems thinking and thinking systems. Syst Dyn Rev. 1994;10(2/3):175-188. doi:10.1002/sdr.4260100206
Meadows DH, Deb W. Thinking in Systems: A Primer. Chelsea Green Publishing Company; 2009.
Swanson RC, Cattaneo A, Bradley E, et al. Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan. 2012;27(Suppl 4):iv54-iv61. doi:10.1093/heapol/czs090
Rogers KH, Luton R, Biggs H, et al. Fostering complexity thinking in action research for change in social-ecological systems. Ecol Soc. 2013;18(2):31. doi:10.5751/ES-05330-180231
Sturmberg JP, Tsasis P, Hoemeke L. COVID-19—an opportunity to redesign health policy thinking. Int J Health Policy Manag. 2020. doi:10.34172/ijhpm.2020.132
Cambon L, Bergeron H, Castel P, Ridde V, Alla F. Quand la réponse mondiale à la pandémie de COVID-19 se fait sans la promotion de la santé. Glob Health Promot. 2021;28(2):92-95. doi:10.1177/17579759211015131
Kurlantzick J. COVID-19 and its effect on inequality and democracy. A study of five large democracies. New York: Council on Foreign Relations. 2021. Accessed November 21, 2021. https://www.cfr.org/report/covid-19-and-its-effect-inequality-and-democracy?utm_medium=social_share%26utm_source=tw
Black S. ‘Simmering under the surface’: how anger has overtaken anxiety amid Covid outbreaks. The Guardian. August 14, 2021. Accessed November 21, 2021. https://www.theguardian.com/australia-news/2021/aug/14/simmering-under-the-surface-how-anger-has-overtaken-anxiety-amid-covid-outbreaks?CMP=Share_AndroidApp_Other
Drucker PF. The Essential Drucker: The Best of Sixty Years of Peter Drucker's Essential Writings on Management Oxford. Taylor & Francis; 2001.
Landemore H. Collective wisdom: old and new. In: Landemore H, Elster J, eds. Collective Wisdom: Principles and Mechanisms. Cambridge University Press; 2012:1-20.
Dietrich F, Spiekermann K. Epistemic democracy with defensible premises. Econ Philos. 2013;29(1):87-120. doi:10.1017/S0266267113000096
Mercuri M. Just follow the science: a government response to a pandemic. J Eval Clin Pract. 2020;26(6):1575-1578. doi:10.1111/jep.13491
Grant S. COVID lockdowns the best of our society, not the worst. ABC News. July 18, 2020. Accessed November 21, 2021. https://www.abc.net.au/news/2021-07-18/covid-lockdown-health-emergency-not-a-crisis/100298320
Sturmberg JP. Knowledge translation in healthcare—towards understanding its true complexities; comment on “Using Complexity and Network Concepts to Inform Healthcare Knowledge Translation”. Int J Health Policy Manag. 2018;7(5):455-458. doi:10.15171/ijhpm.2017.111
Sturmberg JP, Picard M, Aron DC, et al. Health and disease—emergent states resulting from adaptive social and biological network interactions. Front Med. 2019;6:59. doi:10.3389/fmed.2019.00059